What if the next news is we have a partner who can help us in the development and marketing of the sub 1-hour COVID-19 Point of Care modified-ELISA detection test, however there is no specific name mentioned who it is, because of a confidentially agreement. And also they are working toward approval before they can sell the test. Which means the deal would hinge on it getting approval. Would that be the news you want ?
And how much do you think that needing approval would affect the PPS from moving up significantly even though something is in the works getting the test to the market.
News 
Market Data 
Discover 
AI
